Retina Health Center offers patients first non-surgical treatment for debilitating eye disease

2016-11-08T15:00:38-05:00January 10th, 2013|Categories: News|Tags: , |

Retina Health Center is now offering Jetrea,  a new non-surgical treatment option for patients with symptomatic vitreomacular adhesion (VMA), a progressive, debilitating eye disease. Left untreated, VMA may lead to visual distortion, loss in visual acuity and central blindness. Recently approved the U.S. Food and Drug Administration (FDA), Jetrea is the first drug approved to [...]